参考文献
［1］Rosekrans S L，Baan B，Muncan V，et al.Esophageal development and epithelial homeostasis.Am J Physiol Gastrointest Liver Physiol，2015，309：G216-228.
［2］Nakagawa H，Whelan K，Lynch J P.Mechanisms of Barrett's oesophagus：intestinal differentiation，stem cells，and tissue models.Best Pract Res Clin Gastroenterol，2015，29：3-16.
［3］Quante M，Abrams J A，Lee Y，et al.Barrett esophagus：what a mouse model can teach us about human disease.Cell Cycle，2012，11：4328-4338.
［4］DoupéD P，Alcolea M P，Roshan A，et al.A single progenitor population switches behavior to maintain and repair esophageal epithelium.Science，2012，337：1091-1093.
［5］Blevins C H，Iyer P G，Vela M F，et al.The esophageal epithelial barrier in health and disease.Clin Gastroenterol Hepatol，2018，16：608-617.
［6］Karam S M.Lineage commitment and maturation of epithelial cells in the gut.Front Biosci，1999，4：D286-D298.
［7］Arnold K，Sarkar A，Yram M A，et al.Sox2（＋）adult stem and progenitor cells are important for tissue regeneration and survival of mice.Cell Stem Cell，2011，9：317-329.
［8］Karam S M，Leblond C P.Identifying and counting epithelial cell types in the“corpus”of the mouse stomach.Anat Rec，1992，232：231-246.
［9］Barker N，Huch M，Kujala P，et al.Lgr5（＋ve）stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro.Cell Stem Cell，2010，6：25-36.
［10］Willet S G，Mills J C.Stomach organ and cell lineage differentiation：from embryogenesis to adult homeostasis.Cell Mol Gastroenterol Hepatol，2016，2：546-559.
［11］Barker N，van de Wetering M，Clevers H.The intestinal stem cell.Genes Dev，2008，22：1856-1864.
［12］Barker N.Adult intestinal stem cells：critical drivers of epithelial homeostasis and regeneration.Nat Rev Mol Cell Biol，2014，15：19-33.
［13］Clevers H.The intestinal crypt，a prototype stem cell compartment.Cell，2013，154：274-284.
［14］Muñoz J，Stange D E，Schepers A G，et al.The Lgr5 intestinal stem cell signature：robust expression of proposed quiescent“＋4”cell markers.Embo J，2012，31：3079-3091.
［15］de Sousa E M F，de Sauvage F J.Cellular plasticity in intestinal homeostasis and disease.Cell Stem Cell，2019，24：54-64.
［16］Wang Y，Song W，Wang J，et al.Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine.J Exp Med，2020，217：e20191130.
［17］Sato T，Vries R G，Snippert H J，et al.Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.Nature，2009，459：262-265.
［18］Romito A，Cobellis G.Pluripotent stem cells：Current understanding and future directions.Stem Cells Int，2016，2016：9451492.
［19］Clevers H.Modeling Development and disease with organoids.Cell，2016，165：1586-1597.
［20］Kretzschmar K，Clevers H.Organoids：modeling development and the stem cell niche in a dish.Dev Cell，2016，38：590-600.
［21］Yin X，Mead B E，Safaee H，et al.Engineering stem cell organoids.Cell Stem Cell，2016，18：25-38.
［22］Osada S I，Wright C V.Xenopus nodal-related signaling is essential for mesendodermal patterning during early embryogenesis.Development，1999，126：3229-3240.
［23］McCracken K W，Aihara E，Martin B，et al.Wnt/beta-catenin promotes gastric fundus specification in mice and humans.Nature，2017，541：182-187.
［24］McCracken K W，Cata E M，Crawford C M，et al.Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.Nature，2014，516：400-404.
［25］Munera J O，Sundaram N，Rankin S A，et al.Differentiation of human pluripotent stem cells into colonic organoids via transient activation of BMP signaling.Cell Stem Cell，2017，21：51-64.
［26］Spence J R，Mayhew C N，Rankin S A，et al.Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.Nature，2011，470：105-109.
［27］Zhang Y，Yang Y，Jiang M，et al.3D Modeling of esophageal development using human PSCderived basal progenitors reveals a critical role for notch signaling.Cell Stem Cell，2018，23：516-529.
［28］Zorn A M，Wells J M.Vertebrate endoderm development and organ formation.Annu Rev Cell Dev Biol，2009，25：221-251.
［29］McCracken K W，Wells J M.Mechanisms of embryonic stomach development.Semin Cell Dev Biol，2017，66：36-42.
［30］Spence J R，Lauf R，Shroyer N F.Vertebrate intestinal endoderm development.Dev Dyn，2011，240：501-520.
［31］Koike H，Iwasawa K，Ouchi R，et al.Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary.Nature，2019，574：112-116.
［32］McCracken K W，Howell J C，Wells J M，et al.Generating human intestinal tissue from pluripotent stem cells in vitro.Nat Protoc，2011，6：1920-1928.
［33］Rustgi A K.3D human esophageal epithelium steps out from h PSCs.Cell Stem Cell，2018，23：460-462.
［34］Trisno S L，Philo K E D，McCracken K W，et al.Esophageal organoids from human pluripotent stem cells delineate Sox2 functions during esophageal specification.Cell Stem Cell，2018，23：501-515.
［35］Leushacke M，Barker N.Ex vivo culture of the intestinal epithelium：strategies and applications.Gut，2014，63：1345-1354.
［36］Yu Q，Kilik U，Holloway E M，et al.Charting human development using a multi-endodermal organ atlas and organoid models.Cell，2021，184：3281-3298.
［37］Zhang M，Liu Y，Chen Y G.Generation of 3D human gastrointestinal organoids：principle and applications.Cell Regen，2020，9：6.
［38］Li X，Ootani A，Kuo C.An air-liquid interface culture system for 3D organoid culture of diverse primary gastrointestinal tissues.Methods Mol Biol，2016，1422：33-40.
［39］Whelan K A，Muir A B，Nakagawa H.Esophageal 3D culture systems as modeling tools in esophageal epithelial pathobiology and personalized medicine.Cell Mol Gastroenterol Hepatol，2018，5：461-478.
［40］DeWard A D，Cramer J，Lagasse E.Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population.Cell Rep，2014，9：701-711.
［41］Jeong Y，Rhee H，Martin S，et al.Identification and genetic manipulation of human and mouse oesophageal stem cells.Gut，2016，65：1077-1086.
［42］Giroux V，Lento A A，Islam M，et al.Long-lived keratin 15＋esophageal progenitor cells contribute to homeostasis and regeneration.J Clin Invest，2017，127：2378-2391.
［43］Kim T H，Shivdasani R A.Stomach development，stem cells and disease.Development，2016，143：554-565.
［44］Leushacke M，Tan S H，Wong A，et al.Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach.Nat Cell Biol，2017，19：774-786.
［45］Stange D E，Koo B K，Huch M，et al.Differentiated Troy＋chief cells act as reserve stem cells to generate all lineages of the stomach epithelium.Cell，2013，155：357-368.
［46］Burclaff J，Willet S G，Sáenz J B，et al.Proliferation and differentiation of gastric mucous neck and chief cells during homeostasis and injury-induced metaplasia.Gastroenterology，2020，158：598-609.
［47］Busslinger G A，Weusten B L A，Bogte A，et al.Human gastrointestinal epithelia of the esophagus，stomach，and duodenum resolved at single-cell resolution.Cell Rep，2021，34：108819.
［48］Barker N，van Es J H，Kuipers J，et al.Identification of stem cells in small intestine and colon by marker gene Lgr5.Nature，2007，449：1003-1007.
［49］Sato T，Clevers H.Growing self-organizing mini-guts from a single intestinal stem cell：mechanism and applications.Science，2013，340：1190-1194.
［50］Jung P，Sato T，Merlos-Suárez A，et al.Isolation and in vitro expansion of human colonic stem cells.Nat Med，2011，17：1225-1227.
［51］Wang H，Yang Y，Liu J，et al.Direct cell reprogramming：approaches，mechanisms and progress.Nat Rev Mol Cell Biol，2021，22：410-424.
［52］Takahashi K，Tanabe K，Ohnuki M，et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell，2007，131：861-872.
［53］Takahashi K，Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell，2006，126：663-676.
［54］Rony I K，Baten A，Bloomfield J A，et al.Inducing pluripotency in vitro：recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.Cell Prolif，2015，48：140-156.
［55］Hou P，Li Y，Zhang X，et al.Pluripotent stem cells induced from mouse somatic cells by smallmolecule compounds.Science，2013，341：651-654.
［56］Spurrier R G，Speer A L，Hou X，et al.Murine and human tissue-engineered esophagus form from sufficient stem/progenitor cells and do not require microdesigned biomaterials.Tissue Eng Part A，2015，21：906-915.
［57］Nakagawa H，Kasagi Y，Karakasheva T A，et al.Modeling epithelial homeostasis and reactive epithelial changes in human and murine three-dimensional esophageal organoids.Curr Protoc Stem Cell Biol，2020，52：e106.
［58］Sachdeva U M，Shimonosono M，Flashner S，et al.Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.Cancer Lett，2021，509：39-52.
［59］Dong J，Wu X，Zhou X，et al.Spatially-resolved expression landscape and gene-regulatory network of human gastric corpus epithelium.Protein＆Cell，2022：pwac059.
［60］团体标准.人肠道类器官.T/CSCB，2022，2022：0013.
［61］团体标准.人肠癌类器官.T/CSCB，2022，2022：0014.
［62］Sato T，van Es J H，Snippert H J，et al.Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.Nature，2011，469：415-418.
［63］Forbester J L，Goulding D，Vallier L，et al.Interaction of salmonella enterica serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells.Infect Immun，2015，83：2926-2934.
［64］Simmini S，Bialecka M，Huch M，et al.Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2.Nat Commun，2014，5：5728.
［65］Gu W，Wang H，Huang X，et al.SATB2 preserves colon stem cell identity and mediates ileumcolon conversion via enhancer remodeling.Cell Stem Cell，2022，29：101-115.
［66］Dekkers J F，van Vliet E J，Sachs N，et al.Long-term culture，genetic manipulation and xenotransplantation of human normal and breast cancer organoids.Nat Protoc，2021，16：1936-1965.
［67］Bartfeld S，Bayram T，van de Wetering M，et al.In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection.Gastroenterology，2015，148：126-136.
［68］Le Guen L，Marchal S，Faure S，et al.Mesenchymal-epithelial interactions during digestive tract development and epithelial stem cell regeneration.Cell Mol Life Sci，2015，72：3883-3896.(https://www.daowen.com)
［69］Loe A K H，Rao-Bhatia A，Kim J E，et al.Mesenchymal niches for digestive organ development，homeostasis，and disease.Trends Cell Biol，2021，31：152-165.
［70］Eicher A K，Kechele D O，Sundaram N，et al.Functional human gastrointestinal organoids can be engineered from three primary germ layers derived separately from pluripotent stem cells.Cell Stem Cell，2022，29：36-51.
［71］Workman M J，Mahe M M，Trisno S，et al.Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system.Nat Med，2017，23：49-59.
［72］Yui S，Azzolin L，Maimets M，et al.YAP/TAZ-dependent reprogramming of colonic epithelium links ECM remodeling to tissue regeneration.Cell Stem Cell，2018，22：35-49.
［73］Nusse Y M，Savage A K，Marangoni P，et al.Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche.Nature，2018，559：109-113.
［74］Wang Y，Chiang I L，Ohara T E，et al.Long-term culture captures injury-repair cycles of colonic stem cells.Cell，2019，179：1144-1159.
［75］Qu M，Xiong L，Lyu Y，et al.Establishment of intestinal organoid cultures modeling injuryassociated epithelial regeneration.Cell Res，2021，31：259-271.
［76］Castillo-Azofeifa D，Fazio E N，Nattiv R，et al.Atoh1（＋）secretory progenitors possess renewal capacity independent of Lgr5（＋）cells during colonic regeneration.EMBO J，2019，38：e99984.
［77］Sprangers J，Zaalberg I C，Maurice M M.Organoid-based modeling of intestinal development，regeneration，and repair.Cell Death Differ，2021，28：95-107.
［78］Dekkers J F，Wiegerinck C L，de Jonge H R，et al.A functional CFTR assay using primary cystic fibrosis intestinal organoids.Nat Med，2013，19：939-945.
［79］Dekkers J F，Berkers G，Kruisselbrink E，et al.Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.Sci Transl Med，2016，8：344ra84.
［80］Min J，Vega P N，Engevik A C，et al.Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach.Nat Commun，2019，10：5549.
［81］Soutto M，Chen Z，Bhat A A，et al.Activation of STAT3 signaling is mediated by TFF1 silencing in gastric neoplasia.Nat Commun，2019，10：3039.
［82］Bigorgne A E，Farin H F，Lemoine R，et al.TTC7A mutations disrupt intestinal epithelial apicobasal polarity.J Clin Invest，2014，124：328-337.
［83］Schwerd T，Bryant R V，Pandey S，et al.NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.Mucosal Immunol，2018，11：562-574.
［84］Wiegerinck C L，Janecke A R，Schneeberger K，et al.Loss of syntaxin 3 causes variant microvillus inclusion disease.Gastroenterology，2014，147：65-68.
［85］Drubin D G，Hyman A A.Stem cells：the new“model organism”.Mol Biol Cell，2017，28：1409-1411.
［86］Jiang M，Li H，Zhang Y，et al.Transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus.Nature，2017，550：529-533.
［87］Kasagi Y，Chandramouleeswaran P M，Whelan K A，et al.The esophageal organoid system reveals functional interplay between notch and cytokines in reactive epithelial changes.Cell Mol Gastroenterol Hepatol，2018，5：333-352.
［88］Yeshi K，Ruscher R，Hunter L，et al.Revisiting inflammatory bowel disease：Pathology，treatments，challenges and emerging therapeutics including drug leads from natural products.J Clin Med，2020，9：1273.
［89］Dotti I，Mora-Buch R，Ferrer-Picón E，et al.Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis.Gut，2017，66：2069-2079.
［90］Howell K J，Kraiczy J，Nayak K M，et al.DNA methylation and transcription patterns in intestinal epithelial cells from pediatric patients with inflammatory bowel diseases differentiate disease subtypes and associate with outcome.Gastroenterology，2018，154：585-598.
［91］Wehkamp J，Schmid M，Stange E F.Defensins and other antimicrobial peptides in inflammatory bowel disease.Curr Opin Gastroenterol，2007，23：370-378.
［92］Bartfeld S.Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids.Dev Biol，2016，420：262-270.
［93］Bertaux-Skeirik N，Feng R，Schumacher M A，et al.CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation.PLoS Pathog，2015，11：e1004663.
［94］Sebrell T A，Hashimi M，Sidar B，et al.A novel gastric spheroid co-culture model reveals chemokine-dependent recruitment of human dendritic cells to the gastric epithelium.Cell Mol Gastroenterol Hepatol，2019，8：157-171.
［95］Holokai L，Chakrabarti J，Broda T，et al.Increased programmed death-ligand 1 is an early epithelial cell response to Helicobacter pylori infection.PLoS Pathog，2019，15：e1007468.
［96］Morey P，Pfannkuch L，Pang E，et al.Helicobacter pylori depletes cholesterol in gastric glands to prevent interferon gamma signaling and escape the inflammatory response.Gastroenterology，2018，154：1391-1404.
［97］Ettayebi K，Crawford S E，Murakami K，et al.Replication of human noroviruses in stem cellderived human enteroids.Science，2016，353：1387-1393.
［98］Finkbeiner S R，Zeng X L，Utama B，et al.Stem cell-derived human intestinal organoids as an infection model for rotaviruses.mBio，2012，3：e00159-12.
［99］Yin Y，Bijvelds M，Dang W，et al.Modeling rotavirus infection and antiviral therapy using primary intestinal organoids.Antiviral Res，2015，123：120-131.
［100］Leslie J L，Huang S，Opp J S，et al.Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.Infect Immun，2015，83：138-145.
［101］Engevik M A，Engevik K A，Yacyshyn M B，et al.Human Clostridium difficile infection：inhibition of NHE3 and microbiota profile.Am J Physiol Gastrointest Liver Physiol，2015，308：G497-509.
［102］Lamers M M，Beumer J，van der Vaart J，et al.SARS-Co V-2 productively infects human gut enterocytes.Science，2020，369：50-54.
［103］Zhou J，Li C，Liu X，et al.Infection of bat and human intestinal organoids by SARS-Co V-2.Nat Med，2020，26：1077-1083.
［104］Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin，2018，68：394-424.
［105］Lau H C H，Kranenburg O，Xiao H，et al.Organoid models of gastrointestinal cancers in basic and translational research.Nat Rev Gastroenterol Hepatol，2020，17：203-222.
［106］Mc Millin D W，Negri J M，Mitsiades C S.The role of tumour-stromal interactions in modifying drug response：challenges and opportunities.Nat Rev Drug Discov，2013，12：217-228.
［107］Hay M，Thomas D W，Craighead J L，et al.Clinical development success rates for investigational drugs.Nat Biotechnol，2014，32：40-51.
［108］Ben-David U，Siranosian B，Ha G，et al.Genetic and transcriptional evolution alters cancer cell line drug response.Nature，2018，560：325-330.
［109］Barbachano A，Fernandez-Barral A，Bustamante-Madrid P，et al.Organoids and colorectal cancer.Cancers（Basel），2021，13：2657.
［110］Fujii M，Shimokawa M，Date S，et al.A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis.Cell Stem Cell，2016，18：827-838.
［111］van de Wetering M，Francies H E，Francis J M，et al.Prospective derivation of a living organoid biobank of colorectal cancer patients.Cell，2015，161：933-945.
［112］Sachdeva U M，Shimonosono M，Flashner S，et al.Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.Cancer Lett，2021，509：39-52.
［113］Smyth E C，Lagergren J，Fitzgerald R C，et al.Oesophageal cancer.Nat Rev Dis Primers，2017，3：17048.
［114］Zheng B，Ko K P，Fang X，et al.A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia.iScience，2021，24：103440.
［115］Wroblewski L E，Piazuelo M B，Chaturvedi R，et al.Helicobacter pylori targets cancerassociated apical-junctional constituents in gastroids and gastric epithelial cells.Gut，2015，64：720-730.
［116］Sebrell T A，Hashimi M，Sidar B，et al.A novel gastric spheroid co-culture model reveals chemokine-dependent recruitment of human dendritic cells to the gastric epithelium.Cell Mol Gastroenterol Hepatol，2019，8：157-171.
［117］Matano M，Date S，Shimokawa M，et al.Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.Nat Med，2015，21：256-262.
［118］Drost J，van Jaarsveld R H，Ponsioen B，et al.Sequential cancer mutations in cultured human intestinal stem cells.Nature，2015，521：43-47.
［119］Kawasaki K，Fujii M，Sugimoto S，et al.Chromosome engineering of human colon-derived organoids to develop a model of traditional serrated adenoma.Gastroenterology，2020，158：638-651.
［120］Xu P，Becker H，Elizalde M，et al.Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD.Gut，2018，67：1905-1906.
［121］Pleguezuelos-Manzano C，Puschhof J，Rosendahl Huber A，et al.Mutational signature in colorectal cancer caused by genotoxic pks（＋）E.coli.Nature，2020，580：269-273.
［122］Dekkers R，Vijftigschild LA，Vonk A M，et al.A bioassay using intestinal organoids to measure CFTR modulators in human plasma.J Cyst Fibros，2015，14：178-181.
［123］Vijftigschild L A，Berkers G，Dekkers J F，et al.β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.Eur Respir J，2016，48：768-779.
［124］Sayoc-Becerra A，Krishnan M，Fan S，et al.The JAK-inhibitor tofacitinib rescues human intestinal epithelial cells and colonoids from cytokine-induced barrier dysfunction.Inflamm Bowel Dis，2020，26：407-422.
［125］Lloyd K，Papoutsopoulou S，Smith E，et al.Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease.Dis Model Mech，2020，13：dmm044040.
［126］Tullie L，Jones B C，De Coppi P，et al.Building gut from scratch—progress and update of intestinal tissue engineering.Nat Rev Gastroenterol Hepatol，2022，19：417-431.
［127］Jensen T，Blanchette A，Vadasz S，et al.Biomimetic and synthetic esophageal tissue engineering.Biomaterials，2015，57：133-141.
［128］Fordham R P，Yui S，Hannan N R，et al.Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury.Cell Stem Cell，2013，13：734-744.
［129］Sugimoto S，Kobayashi E，Fujii M，et al.An organoid-based organ-repurposing approach to treat short bowel syndrome.Nature，2021，592：99-104.
［130］Nikolaev M，Mitrofanova O，Broguiere N，et al.Homeostatic mini-intestines through scaffoldguided organoid morphogenesis.Nature，2020，585：574-578.
［131］Meran L，Massie I，Campinoti S，et al.Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure.Nat Med，2020，26：1593-1601.
［132］Grikscheit T C，Ogilvie J B，Ochoa E R，et al.Tissue-engineered colon exhibits function in vivo.Surgery，2002，132：200-204.
［133］Cromeens B P，Liu Y，Stathopoulos J，et al.Production of tissue-engineered intestine from expanded enteroids.J Surg Res，2016，204：164-175.
［134］Purnell B A.Ethics of organoid research.Science，2017，355：257-259.
［135］Bredenoord A L，Clevers H，Knoblich J A.Human tissues in a dish：The research and ethical implications of organoid technology.Science，2017，355：eaaf9414.
［136］Arjmand B，Rabbani Z，Soveyzi F，et al.Advancement of organoid technology in regenerative medicine.Regen Eng Transl Med，2022：1-14.